Explore By Subject Area   
Return Home
Register Here Menu

Immuno-Oncology 360°

Date: Feb 10, 2026 - Feb 12, 2026

Location: Boston, MA

Day One: Tuesday, February 10, 2026
Showing Events in 1 Track from 07:30am to 08:10am
Registration & Morning Remarks
7:30AM - 8:00AM
Registration
8:00AM - 8:10AM
IO360° Opening Remarks
Showing Events in 1 Track from 08:15am to 09:05am
Opening Keynote
8:15AM - 8:25AM
Presenting the IO360° Lifetime Achievement Award
8:25AM - 8:50AM
Keynote: Checkpoint Blockade and Beyond: Charting the Next Era of Immuno-Oncology
Keynote Speaker:
Jedd Wolchok, MD, PhD, Meyer Director of the Sandra and Edward Meyer Cancer Center and Professor of Medicine, Weill Cornell Medicine
8:50AM - 9:05AM
Immunotherapy Through the Eyes of Patient and Physician
Fireside Guests:
Brendan Connors, Patient, Advocate
Jedd Wolchok, MD, PhD, Meyer Director of the Sandra and Edward Meyer Cancer Center and Professor of Medicine, Weill Cornell Medicine
Showing Events in 1 Track from 09:05am to 09:25am
New Technologies in Transformational Biology
9:05AM - 9:25AM
Beyond Cytotoxicity: Granzyme B ADCs – A New Paradigm in Immuno-Oncology Payload Discovery
Speaker:
Claire Thuning-Roberson, PhD, CEO, AbBC Therapies
Showing Events in 1 Track from 09:25am to 10:05am
Grand Opening of the IO360° Networking Café
9:25AM - 10:05AM
Grand Opening of the IO360° Networking Café
Showing Events in 1 Track from 10:05am to 10:45am
New Technologies in Transformational Biology (Continued)
10:05AM - 10:25AM
AstraZeneca’s Bet on In Vivo CAR-T: A Preclinical Perspective
Speaker:
Mark Cobbold, PhD, SVP IO and Cell Therapy Discover, AstraZeneca
10:25AM - 10:45AM
Antisense Oligonucleotides (ASOs) for Cancer: Why This Modality’s Moment Has Arrived
Speaker:
Zdravka Medarova, PhD, CSO & Co-founder, TransCode Therapeutics
Showing Events in 1 Track from 11:00am to 11:10am
10 Min Health Break
11:00AM - 11:10AM
10 Min Health Break
Showing Events in 1 Track from 11:10am to 12:20pm
Morning Tracks
11:10AM - 12:20PM
Two Track Choices: IO Novel Technologies Showcase
Participating Companies:
Showing Events in 2 Tracks from 12:20pm to 01:35pm
Lunch and Networking
12:20PM - 1:35PM
Lunch & 1:1 Partnering Meetings Begin
Women's Luncheon
12:20PM - 1:35PM
3rd Annual Women Leaders in IO Panel & Luncheon
Moderator:
Marisa Dolled-Filhart, PhD, Global Team Lead, Early Oncology; Asset and Portfolio Management, Daiichi Sankyo US
Panelists:
Theresa LaVallee, PhD, Chief Scientific & Development Officer, Coherus Oncology
Showing Events in 2 Tracks from 01:40pm to 03:20pm
TRACK 1: New Tech in Transformational Biology
1:40PM - 2:00PM
AI-Driven Protein Design: The Next Frontier in TCR-Based Immuno-Oncology
Speaker:
John Connolly, PhD, CSO, Parker Institute for Cancer Immunotherapy (PICI)
2:00PM - 2:20PM
Next-Generation Cancer Vaccines: Mining the Dark Genome for Novel Shared Antigens
Speaker:
Jon Moore, PhD, CSO, Epitopea
2:35PM - 2:55PM
Cytokine-Based ADCs: IL-12 and IL-18 as Immune-Modulating Payloads
2:55PM - 3:15PM
CAR-DCs to Improve Antitumor Immunity
Speaker:
Carl DeSelm, MD, PhD, Assistant Professor, Radiation Oncology & Principle Investigator, Washington University in St. Louis
TRACK 2: Imaging-Driven Innovation in IO
1:40PM - 2:00PM
The Imaging Reality Check: Practical Insights from a Leading IO Trialist
Speaker:
Diwakar Davar, MD, Associate Professor, Clinical Director, Melanoma and Skin Cancer Program, UPMC Hillman Cancer Center
2:00PM - 2:40PM
Panel: Imaging Lessons from IO 1.0 to Shape IO 2.0: From Smarter Design to Meaningful Impact
Speaker:
David Leung, MD, PhD, Head of Imaging, Daiichi Sankyo
2:40PM - 3:20PM
Panel: Measuring What Matters: Using Biomarkers to Guide Patient Selection and Treatment in IO
Panelists:
Greg Goldmacher, MD, PhD, MBA, Associate VP, Clinical Research; Head, Clinical Imaging & Pathology, Merck Research Laboratories
Catherine Hines, PhD, Executive Director and Head, Clinical Imaging, GSK
Dejan Knezevic, PhD, Senior Director, Pharma Partnerships, Natera
Showing Events in 1 Track from 03:25pm to 04:05pm
Afternoon Networking Break
3:25PM - 4:05PM
Afternoon Networking Break and Partnering Meetings
Showing Events in 2 Tracks from 04:10pm to 05:40pm
TRACK 1: Breakthroughs in Translational Science Part 1
4:10PM - 4:30PM
What Drives an Effective Anti-Tumor Immune Response? Insights from Blood-Borne and Solid Tumors
Speaker:
Erik Manting, PhD, CEO, Mendus
4:45PM - 5:05PM
Targeting IL-27 to Activate Antitumor Immunity: Insights from Casdozokitug
Speaker:
Sruthi Ravindranathan, PhD, Senior Scientist, Translational Medicine, Coherus Oncology
5:20PM - 5:40PM
New Translational Insights from the VG161 Oncolytic Virotherapy Study
Speaker:
William Jia, PhD, CSO & Co-founder, Virogin Biotech
TRACK 2: Imaging-Driven Innovation in IO
4:10PM - 4:30PM
Understanding, Detecting and Harnessing Immunogenic Cell Death in IO
Speaker:
Lorenzo Galluzzi, PhD, Associate Professor Cancer Signaling and Microenvironment Research Program, Fox Chase Cancer Center, Temple Health
4:30PM - 5:10PM
Panel - From Hype to Impact: Where AI in Imaging Is Moving the Needle in IO Development
Panelists:
Greg Goldmacher, MD, PhD, MBA, Associate VP, Clinical Research; Head, Clinical Imaging & Pathology, Merck Research Laboratories
Diederik Grootendorst, PhD, Director, Global Oncology Imaging, Bristol Myers Squibb
Petr Jordan, PhD, CTO, Onc.AI
Jayant Narang, MD, Sr Medical Director, Clinical Oncology Imaging Lead, Preclinical and Translational Sciences, Takeda Pharmaceuticals
5:10PM - 5:40PM
Improving Tumor Assessment Using Growth Dynamics
Speakers:
Susan E. Bates, Professor of Medicine / Director, Translational Cancer Medicine, Columbia University Medical Center
Antonio "Tito" Fojo, MD, Professor of Medicine / Co-Director, Columbia Adrenal Surgery Center, Columbia University Medical Center
Showing Events in 1 Track from 05:50pm to 06:50pm
12th Annual Networking Reception
5:50PM - 6:50PM
12th Annual Networking Reception & 1:1 Partnering Meetings
Showing Events in 1 Track from 07:30am to 08:10am
Registration & Morning Remarks
7:30AM - 8:00AM
Registration
8:00AM - 8:10AM
IO360° Opening Remarks
Showing Events in 1 Track from 08:15am to 09:05am
Opening Keynote
8:15AM - 8:25AM
Presenting the IO360° Lifetime Achievement Award
8:25AM - 8:50AM
Keynote: Checkpoint Blockade and Beyond: Charting the Next Era of Immuno-Oncology
Keynote Speaker:
Jedd Wolchok, MD, PhD, Meyer Director of the Sandra and Edward Meyer Cancer Center and Professor of Medicine, Weill Cornell Medicine
8:50AM - 9:05AM
Immunotherapy Through the Eyes of Patient and Physician
Fireside Guests:
Brendan Connors, Patient, Advocate
Jedd Wolchok, MD, PhD, Meyer Director of the Sandra and Edward Meyer Cancer Center and Professor of Medicine, Weill Cornell Medicine
Showing Events in 1 Track from 09:05am to 09:25am
New Technologies in Transformational Biology
9:05AM - 9:25AM
Beyond Cytotoxicity: Granzyme B ADCs – A New Paradigm in Immuno-Oncology Payload Discovery
Speaker:
Claire Thuning-Roberson, PhD, CEO, AbBC Therapies
Showing Events in 1 Track from 09:25am to 10:05am
Grand Opening of the IO360° Networking Café
9:25AM - 10:05AM
Grand Opening of the IO360° Networking Café
Showing Events in 1 Track from 10:05am to 10:45am
New Technologies in Transformational Biology (Continued)
10:05AM - 10:25AM
AstraZeneca’s Bet on In Vivo CAR-T: A Preclinical Perspective
Speaker:
Mark Cobbold, PhD, SVP IO and Cell Therapy Discover, AstraZeneca
10:25AM - 10:45AM
Antisense Oligonucleotides (ASOs) for Cancer: Why This Modality’s Moment Has Arrived
Speaker:
Zdravka Medarova, PhD, CSO & Co-founder, TransCode Therapeutics
Showing Events in 1 Track from 11:00am to 11:10am
10 Min Health Break
11:00AM - 11:10AM
10 Min Health Break
Showing Events in 1 Track from 11:10am to 12:20pm
Morning Tracks
11:10AM - 12:20PM
Two Track Choices: IO Novel Technologies Showcase
Participating Companies:
Showing Events in 2 Tracks from 12:20pm to 01:35pm
Lunch and Networking
12:20PM - 1:35PM
Lunch & 1:1 Partnering Meetings Begin
Women's Luncheon
12:20PM - 1:35PM
3rd Annual Women Leaders in IO Panel & Luncheon
Moderator:
Marisa Dolled-Filhart, PhD, Global Team Lead, Early Oncology; Asset and Portfolio Management, Daiichi Sankyo US
Panelists:
Theresa LaVallee, PhD, Chief Scientific & Development Officer, Coherus Oncology
Showing Events in 2 Tracks from 01:40pm to 03:20pm
TRACK 1: New Tech in Transformational Biology
1:40PM - 2:00PM
AI-Driven Protein Design: The Next Frontier in TCR-Based Immuno-Oncology
Speaker:
John Connolly, PhD, CSO, Parker Institute for Cancer Immunotherapy (PICI)
2:00PM - 2:20PM
Next-Generation Cancer Vaccines: Mining the Dark Genome for Novel Shared Antigens
Speaker:
Jon Moore, PhD, CSO, Epitopea
2:35PM - 2:55PM
Cytokine-Based ADCs: IL-12 and IL-18 as Immune-Modulating Payloads
2:55PM - 3:15PM
CAR-DCs to Improve Antitumor Immunity
Speaker:
Carl DeSelm, MD, PhD, Assistant Professor, Radiation Oncology & Principle Investigator, Washington University in St. Louis
TRACK 2: Imaging-Driven Innovation in IO
1:40PM - 2:00PM
The Imaging Reality Check: Practical Insights from a Leading IO Trialist
Speaker:
Diwakar Davar, MD, Associate Professor, Clinical Director, Melanoma and Skin Cancer Program, UPMC Hillman Cancer Center
2:00PM - 2:40PM
Panel: Imaging Lessons from IO 1.0 to Shape IO 2.0: From Smarter Design to Meaningful Impact
Speaker:
David Leung, MD, PhD, Head of Imaging, Daiichi Sankyo
2:40PM - 3:20PM
Panel: Measuring What Matters: Using Biomarkers to Guide Patient Selection and Treatment in IO
Panelists:
Greg Goldmacher, MD, PhD, MBA, Associate VP, Clinical Research; Head, Clinical Imaging & Pathology, Merck Research Laboratories
Catherine Hines, PhD, Executive Director and Head, Clinical Imaging, GSK
Dejan Knezevic, PhD, Senior Director, Pharma Partnerships, Natera
Showing Events in 1 Track from 03:25pm to 04:05pm
Afternoon Networking Break
3:25PM - 4:05PM
Afternoon Networking Break and Partnering Meetings
Showing Events in 2 Tracks from 04:10pm to 05:40pm
TRACK 1: Breakthroughs in Translational Science Part 1
4:10PM - 4:30PM
What Drives an Effective Anti-Tumor Immune Response? Insights from Blood-Borne and Solid Tumors
Speaker:
Erik Manting, PhD, CEO, Mendus
4:45PM - 5:05PM
Targeting IL-27 to Activate Antitumor Immunity: Insights from Casdozokitug
Speaker:
Sruthi Ravindranathan, PhD, Senior Scientist, Translational Medicine, Coherus Oncology
5:20PM - 5:40PM
New Translational Insights from the VG161 Oncolytic Virotherapy Study
Speaker:
William Jia, PhD, CSO & Co-founder, Virogin Biotech
TRACK 2: Imaging-Driven Innovation in IO
4:10PM - 4:30PM
Understanding, Detecting and Harnessing Immunogenic Cell Death in IO
Speaker:
Lorenzo Galluzzi, PhD, Associate Professor Cancer Signaling and Microenvironment Research Program, Fox Chase Cancer Center, Temple Health
4:30PM - 5:10PM
Panel - From Hype to Impact: Where AI in Imaging Is Moving the Needle in IO Development
Panelists:
Greg Goldmacher, MD, PhD, MBA, Associate VP, Clinical Research; Head, Clinical Imaging & Pathology, Merck Research Laboratories
Diederik Grootendorst, PhD, Director, Global Oncology Imaging, Bristol Myers Squibb
Petr Jordan, PhD, CTO, Onc.AI
Jayant Narang, MD, Sr Medical Director, Clinical Oncology Imaging Lead, Preclinical and Translational Sciences, Takeda Pharmaceuticals
5:10PM - 5:40PM
Improving Tumor Assessment Using Growth Dynamics
Speakers:
Susan E. Bates, Professor of Medicine / Director, Translational Cancer Medicine, Columbia University Medical Center
Antonio "Tito" Fojo, MD, Professor of Medicine / Co-Director, Columbia Adrenal Surgery Center, Columbia University Medical Center
Showing Events in 1 Track from 05:50pm to 06:50pm
12th Annual Networking Reception
5:50PM - 6:50PM
12th Annual Networking Reception & 1:1 Partnering Meetings
Previous
Day One
Tuesday, February 10, 2026

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.